·Review· Current Issue· ·Achieve· ·Search Articles· ·Online Submission· ·About IJO· PMC
Citation: Wong KH, Kam KW, Chen LJ, Young AL. Corneal
blindness and current major treatment concern-graft scarcity. Int J
Ophthalmol 2017;10(7):1154-1162
Corneal blindness and current major treatment concern-graft scarcity
Kah Hie Wong1, Ka Wai Kam2,
Li Jia Chen1,2, Alvin L. Young1,2
1Department of Ophthalmology and Visual Sciences, Chinese
University of Hong Kong, Hong Kong, China
2Department of Ophthalmology and Visual Sciences, Prince of Wales
Hospital, Hong Kong, China
Correspondence
to: Alvin L. Young. Department of Ophthalmology and Visual Sciences,
Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, New Territories, Hong
Kong, China. youngla@ha.org.hk
Received:
2016-06-04
Accepted: 2016-09-26
According
to World Health Organization, the global prevalence of blindness in 2010 was 39
million people, among which 4% were due to corneal opacities. Often, the sole
resort for visual restoration of patients with damaged corneas is corneal
transplantation. However, despite rapid developments of surgical techniques,
instrumentations and immunosuppressive agents, corneal blindness remains a
prevalent global health issue. This is largely due to the scarcity of good
quality corneal grafts. In this review, the causes of corneal blindness, its
major treatment options, and the major contributory factors of corneal graft
scarcity with potential solutions are discussed.
KEYWORDS: corneal blindness; keratoplasty; corneal graft; corneal donation; eye
banking
DOI:10.18240/ijo.2017.07.21
Citation: Wong KH, Kam KW, Chen LJ, Young AL. Corneal
blindness and current major treatment concern-graft scarcity. Int J
Ophthalmol 2017;10(7):1154-1162
Corneal disease is a
leading cause of visual impairment[1-2], currently ranking as the fourth commonest cause of global blindness
after cataract, glaucoma and age-related macular degeneration[3-5]. According to World Health Organization (WHO), among the 39 million
people who were blind, 4% were due to corneal opacities[6-7]. The major causes of corneal blindness are trachoma, corneal ulcers,
xerophthalmia, ophthalmia neonatorum, viral infections, traditional eye
medicines, onchocerciasis, leprosy, and ocular trauma[8]. Most of the causes
of corneal blindness are preventable if timely treatment or better access to
healthcare is provided[8-9]. Unfortunately when many of these conditions were left untreated in the
acute stage, the only treatment option remaining for patients with a damaged
cornea is corneal transplantation[2].
Since 1961, over 1
500 000 people had their sight restored through corneal transplantation[10]. In 2012, there were
283 530 corneas procured from 82 countries [41% (116 990) from United States,
14% (40 000) from India] and stored in 742 eye banks[11]. About 8% of the
procured corneas (23 247) were exported from 9 countries [85% (19 546) from the
United States, 9% (2000) from Sri Lanka, and 3% (600) from Italy][11]. However, almost 100
000 (35%) corneas were not selected for transplantation after quality control,
which was mainly based on serology of donor blood for human immunodeficiency
virus (HIV) and hepatitis B and C, and on the number and quality of corneal
endothelial cells[12]. These measures aimed to reduce the risks of transmission of infection
and primary graft failure, and to ensure acceptable graft survival. Finally 184
576 corneal transplants were performed in 116 countries in 2012[11]. This number however
was still far from reaching the 12.7 million patients awaiting corneal
transplantation in 2012[11].
Corneal Transplantation Corneal transplantation is the commonest organ transplantation in human[13]. Unlike
other solid organs, tissue matching is not routinely required in corneal
transplantation.
Corneal
transplantation has the highest success rate among all kinds of organ
transplantations, achieving up to 94% of mean 1-year graft survival rate[14]. This
success is contributed largely by 1) the relatively low graft rejection rate
due to its avascular nature and scarcity of immunogenic tissues; 2) relative
absence of systemic disease transmitted through transplanted corneas; 3) the
emerging and maturation of lamellar keratoplasty such as Descemet’s stripping
automated endothelial keratoplasty (DSAEK)[14] and deep anterior
lamellar keratoplasty (DALK)[15]; 4) advancements of instrumentation such as viscoelastics, diamond
knives, ultrasonic pachymetry, intraoperative optical coherence tomography,
artificial anterior chambers, advanced microkeratomes, and femtosecond laser[15].
Among the many
subtypes of keratoplasties, the commonly performed ones are penetrating
keratoplasty (PK), DALK and DSAEK[16]. PK, which involves full-thickness cornea replacement, is the
traditional, dominant corneal transplantation performed over more than half a
century and has successfully tackled most causes of corneal blindness[17-18]. Two decades ago, PK was the only definitive surgical treatment for
pseudophakic bullous keratopathy and Fuchs endothelial dystrophy[19].
In the last two decades, lamellar keratoplasty
techniques resurged. With the concept of targeted replacement of diseased
layers of cornea, the wastage of graft has been minimised, as a single donor
button can be utilised for more than one patient[16]. The
residual donor corneoscleral rim could be further divided into four pieces and
used in other ophthalmic surgeries such as glaucoma operations, or when
additional corneoscleral tissue is needed (e.g. patching or repairs)[16,20]. Therefore, the maximum number of patients that can be benefited from
one single corneal graft is increased to 6 patients[16,21].
With the advancements
of surgical techniques and instruments for keratoplasty[15,22-23], rapid evolution of eye-bank preparation of corneal tissue[24], and
continuous emergence of novel effective immunosuppressive agents (e.g.
tacrolimus, cyclosporine, sphingosine 1-phosphate receptor agonists[25-29]), the overall life expectancy of a corneal graft has increased, and the
safety, effectiveness and visual outcomes of lamellar keratoplasty are now
comparable to, if not better than, standard PK[14,17,30-31].
Persistent Treatment Concern of Corneal Blindness-graft Scarcity In 2012, it was estimated that only 1 cornea was available for 70 people
in need[11]. Approximately 53% of the world’s population had no access to corneal
transplantation, while only 35.7% had satisfactory access[11]. The
median waiting time for receiving a corneal transplant was 6.5mo (interquartile
range=1-24mo), whilst the waiting time in 53% of the world’s populations could
not be estimated because most patients in those countries never received a
graft[11].
Among the 12.7
million patients awaiting corneal transplantation in 2012 globally, there were
7 million in India, but only 25 000 transplants were performed in the same year[11]. China
had 2 million patients on the waiting list, but fewer than 8000 corneal
transplantations were performed in 2012[11]. In Hong
Kong, there were about 7.3 million people (by December 2015) but on average
only 239 pieces of corneas were donated each year[32]. The number of
patients on the waiting list in Hong Kong as on December 31, 2014 was almost
twice the number of annual supply[32]. Despite active promotion of organ donation by government and relevant
organisations, Hong Kong had approximately 8 times lower corneal donation rate
per capita than United States in 2014. Meanwhile, Malaysia, Indonesia, Vietnam
and Korea were unable to procure more than 20 to 30 corneas per year[33].
Around the world,
there are 742 eye banks identified[11]. There are 28
countries which only have 1 eye bank each, while 30 countries have 2 to 5 eye
banks each, and only 16 countries have more than 5 eye banks each[11]. The number of
corneas received annually by each eye bank ranged from 1 to 7000 (median=168,
interquartile range: 58-377)[11].
The situation of the
generally unfavourable organ donation rate was aggravated by a high selective
refusal to eye donation. The fact that eyes are not simply biologic but have
much deeper and wider meaning towards each individual, has contributed to the
high reluctance to donation[13]. The rationales underlying the reluctance are complex[34].
Macroscopic factors such as international, national, local governmental and
institutional policies and eye-banking systems exert variable influences on the
ease of cornea donation, procurement, exportation or importation, storage,
distribution and transplantation. The knowledge, awareness, attitude and
beliefs of potential donors and their families regarding corneal donation and
transplantation influence their willingness and decision to donate. Organ
donation rates are also affected by communication skills of healthcare
providers with potential donor families, legislation, presumed consent system,
donor availability, transplantation system organisation and infrastructure,
wealth and investment in healthcare[35].
Government,
legislation and hospital policies The lack of efficient notification system has led to wastage of
potential grafts due to suboptimal timing of raising corneal donation request.
In 1998, the United States Health Care Financing Administration (HCFA, now the
Centers for Medicare and Medicaid Services) amended the federal Conditions of
Participation (COP)[36]. Since then, hospitals had been required to notify
their local organ procurement organisation (OPO) about individuals who decease
or whose death is “imminent”[36]. This is to ensure timely offering of eye, tissue and organ donation
option to the families, because the decision to accept donation request also
depends on the time elapsed from death or the time of grave prognosis to the
time of raising corneal donation request[37].
In Hong Kong, since the establishment of Transplant
Coordination Service in August 1988 under the Hospital Services Department, the
organ procurement rate increased from below 10% to above 40%[38-39]. This service was strengthened in 1994 by cluster-based regional
coordinators to better coordinate different disciplines during the period of
organ procurement and transplantation[38-40]. These coordinators not only approached and convinced the families to
consent for organ donation, but also promoted the public awareness to organ
donation[38,40]. According to legislation of Hong Kong, one can only donate his/her
tissues or organs with the consent of family. According to the transplant
coordinators in Hong Kong, family disharmony was one of the main reasons of
refusal[38]. Moreover, Hong Kong is among the 45% of cornea-procuring countries and
regions that practise the opt-in system, which has significantly lower donation
rate than the opt-out system[11,38]. A survey revealed that only 28% of respondents in Hong Kong agreed to
presumed consent for organ donation, meanwhile 66% objected[38,41]. This might be attributed to the traditional Chinese belief to preserve
body integrity after death[38,42].
To ameliorate the local corneal donation rate, Hong
Kong modified the corneal donation eligibility criteria. Since February 2013,
all solid or metastatic cancer patients (except intraocular cancers) are
eligible to donate their corneas[43]. Furthermore, in addition to conventional paper application, a
user-friendly website (https://www.codr.gov.hk/codr/ Internet.do) has been
launched to encourage people, especially the younger generations, to register
as corneal donors.
Eye banking services One main cause of graft scarcity is the lack of large professional eye
banks that can effectively perform the four key eye bank functions: approach
and consent, recovery, processing, and distribution[44-45]. India, the country with second largest number of people with blindness
(8075 million in 2010 according to WHO)[7], has the highest
number of eye banks (238) in the world[11]. This is followed by
United States (84). However, there was a huge contrast in the annual number of
procured grafts per bank between India (168) and United States (1393)[11].
The barriers of underdevelopment of eye banking
systems include the lack of trained staff, inefficient operations,
affordability (for equipment and storage media), sociocultural perceptions
related to eye donation, restrictive political laws, and poor distribution,
utilization and adherence to medical standards[44-46].
The implementation of efficient corneal distribution
program has resulted in great increase of corneal donation and utilization
rates. The establishment of a non-profit global health organisation such as
SightLife, could allow excess corneas that are not used in the United State to
be sent to other countries in demand[47]. The joint effort
between Eye Bank Association of India and SightLife, i.e. EBAI-SightLife
Cornea Distribution System, has led to an increase in cornea utilization rate
by 379% from 2325 in 2009 to 11 143 in 2013[45,47].
The development of professional eye bank managers and
Hospital Cornea Recovery Programs (HCRP) has further increased the supply of
corneal grafts[44]. The training programs of efficient eye-banking skills provided by
SightLife and Ramayamma International Eye Bank (RIEB-Asia’s largest eye bank in
India) have greatly improved graft donation and utilisation around the world[47-48]. HCRP involves trained eye donation counsellors, who are stationed in
large hospitals to offer grief counselling and directly motivate potential
donor families to gain consent[44]. This contrasts to the typical Indian eye bank operation, which uses a
“voluntary” program that relies on general public awareness and realization of
one's social responsibility towards the corneal blindness[44]. According to the
Eye Bank Association of India, the overall Indian eye bank tissue utilization
increased from 38% through primarily voluntary collection to 72% after the
adoption of HCRP model in 8 eye banks[44]. Of the tissues
recovered from 13 012 donors by RIEB between 1991 and 2014, 67% was achieved
through the motivational approach of eye donation counsellors[48].
The availability of expertise to pre-cut tissues in
eye banks is important to reduce wastage of corneal grafts and maximise the
supply of cornea tissue. Many eye banks have started to provide pre-cut tissues
for local utilization and international tissue sharing, however such expertise
would require advanced eye bank training[45].
The high costs of equipment and storage media such as
McCarey-Kaufman (MK) media (Bausch & Lomb), Optisol GS (Bausch & Lomb),
and LIFE4℃ (Numedis) have contributed to the affordability issue in the
operation of an eye bank. One alternative may be to adopt a less expensive storage
medium, such as Cornisol (Aurolab, Madurai, India) which is estimated to
perform similarly to Optisol GS at approximately 65% of the cost[45].
Knowledge and attitude Both knowledge and attitudes affect the willingness and commitment to
organ donation[49-52]. The attitudes towards organ donation are inconsistent across different
countries and populations. The attitudes had been found favourable among the
public, e.g. United States[49,53], South
Africa (urban populations)[54] and Saudi Arabia[55], healthcare providers/ professionals (HCP) in
Canada[56-57] and Croatia[58], and students in New Zealand[59]. However,
the contrast was observed in non-blood-donors in Hong Kong[50,60], Turkish students of healthcare-related courses[61], rural
populations in Saudi Arabia[50], minority ethnic groups in the United Kingdom and North America[62], and Turkish mosque imams[63-64].
Studies have consistently shown the inadequacy in the
knowledge of general public and medical personnel regarding the legal and
medical status of death[50,57,65-67], organ donation[1,50,57,59,67-69] and organ transplantation[1,68]. However,
even if the knowledge of organ donation was known, it was mainly about kidney,
liver and heart[67,69].
Lower level of
socioeconomic status[34,37,70], formal
education[34,37,70-72] and knowledge
regarding corneal donation[72] have been associated with lower likelihood of believing the
justification of corneal and organ donation and lower likelihood of corneal
donation.
Earlier and more
exposure to information on corneal donation may result in more favourable
attitude and belief in donation, and improve the donation rate[72]. Some effective
means to educate the public about corneal donation and develop more positive
attitudes towards corneal donation include mass media[64], such as television[50],
Facebook[73], billboards, awareness campaigns[72,74] and leaflet distribution[58], or through HCPs[64].
The “tomorrow’s
donors”, i.e. the adolescents who are at the age eligible of applying
driver’s license, are eligible to register for corneal and organ donation in
most countries[75]. Therefore, school-based education programs for adolescents may be an
effective strategy to improve corneal and organ donation rates[68]. These educational
programs need additional, regular evaluations and supportive evidences to
delineate their impact on affirmative donor registration and realized donations[75].
Identity and visibility The eyes represent a long tradition of visual primacy in all aspects of
culture[13]. When we are engaged with an individual, the first thing that we would
look at and interact with is often his or her eyes. In daily communication
process, eye contact, eye movement and the messages imparted via the
emotions of the eyes make up the main part of facial expressions.
An interview revealed
how great the distortion of one’s image in the heart of relatives if the
beloved decedent has his or her eyes removed in part or in whole[76]. This is
because the removal of eyes has similar meaning to the alteration of one’s
identity, even when the eyes are forever shut after one is deceased[76]. Therefore,
the selective refusal of corneal and eye donation is prominent[13,76].
This is further
aggravated by the visibility of eyes as an external organ, as opposed to the
internal organs that cannot be visualized. Bodily disfigurement is often a
major concern during the request of corneal donation from families, as it is
relatively easier for relatives to accept the physical absence of the
decedents’ internal organs after procurement[76], and be
less concerned about the influence on funeral arrangement[71,76].
HCPs and organ
procurement staff have the responsibility to address these concerns, and
explain that the operative wound is small and artificial cornea or eyeball will
be replaced after procurement. Furthermore, corneal donation may be viewed as
the continuity of the relationship with decedents in another manner as the
decedents can continue to “see” the world through the corneal recipients by
“giving a life to a dead eye”[77].
Strengthening the role of healthcare providers/professionals? HCPs were infrequently reported as the source of information on corneal and
organ donation[49]. At least 90% of respondents
in both rural and urban areas of a study in Saudi Arabia reported “none” or
“little” contribution of knowledge about organ donation and transplantation by
HCPs[50]. However, 60% of respondents would like
their HCPs to provide information of donation to them[49].
The quality of explanation and clarification
of the meaning of brain death affects the decision-making of donation[37,78-79]. However,
in fact, many HCPs, including nurses and physicians of intensive care units,
did not have adequate knowledge on organ donation in general[80-82], on brain death[82] and religious barriers to organ donation[57]. In addition, many physicians were unable to
recognize the importance of decoupling the discussion of brain death from the
donation of cornea and organs[83].
In comparison to
solid organ donation, HCPs were less knowledgeable about the cornea donation
criteria, less successful in the identification of eligible corneal donors and
less efficient in the process of procurement of corneas as compared to that of
solid organs[84]. Not only did many eligible corneas miss their chances to be identified,
even if they were, many nurses and physicians were reluctant to approach
potential organ donors and their relatives[56-57]. The lack of knowledge and natural repellence against facing negative
emotions had contributed to the ambivalence in breaking news of the patient's
grave prognosis or death to families and in requesting the corneal donation
from them[83].
The knowledge deficit
in corneal donation may be traced to the lack of such emphasis in the curricula
of healthcare-related courses. A significant number (63.1%) of students of
medicine, nursing, dentistry and health technician courses are not familiar
with tissue and organ donation process[61]. The mean
and median scores on knowledge level of organ donation among medical students
are less than 50%[52,85]. In addition, low exposure to potential organ donors has led to less
favourable knowledge level, attitude and professional involvement of organ
donations[56].
As the vital bridge
to corneal donors, HCPs need to be armed with up-to-date knowledge. Education
interventions of HCPs should start from undergraduate level to build solid
foundation of knowledge on corneal donation[85-86]. The organ procurement units, government or relevant organisations such
as Lions Eye Bank should provide regular training programs to current and
future HCPs on corneal donation, as this significantly enhances the relevant
knowledge and the confidence of HCPs to approach potential donors and their
families[51,80-81]. These education programs can not only promote HCPs to have greater
willingness and confidence to approach decedents’ families to make corneal
donation request, but also motivate the HCPs themselves to explore organ
donation deeper and take up subsequent interval training[81].
Many HCPs have
positive attitude and support organ donation in principle[56-58,80]. However, there is significant discrepancy in the number of HCPs who
support in principle and those who register themselves as organ donors[57,80]. Through education, not only can HCPs raise the corneal donation rates
among patients, it also encourages HCPs to lead corneal donation with own
actions[51,81].
The hospital
experiences of the potential donors’ families can also affect their
decision-making[71,87]. During the care of patients at their end of lives, satisfactory
hospital experiences and attitude towards patients and their families should be
provided in a more scrupulous, painstaking and empathic manner.
Religion Religion is an influential factor in the decision-making of organ
donation[66,68]. In a survey of optometry students of University California, the leading
reason of reluctance to donate cornea was religious reason[68].
Christianity had been demonstrated as a positive motivator to organ donation[66,70]. Among all cornea donors in 2012, 77.1%
were Christians, 14.2% Hindus, 3.7% Muslims, and 2.6% Buddhists[11]. The
remaining 2.4% cornea donors in 2012 believed in Chinese Traditional religion
(1.8%), Atheism (0.4%) and Judaism (0.2%)[11].
In countries with
strong religious influence, religious officials and mosque imams who are well
educated on corneal donation can act as important media to encourage the
members of society to donate[69,88]. Also, religious leaders can raise public discussion of issues through
extensive media coverage, allowing them to promote pro-social behaviour and
positively affect public health[89].
Therefore, the
effectiveness in raising corneal donation may be further enhanced by the
collaboration of HCPs and mass media with these influential religious figures.
Focused educational program can be provided to the general or specific
religious community in worship places to provide a religious support to corneal
donation[88], to improve the knowledge, perceptions and beliefs about corneal
donation and to clear the relevant religious misconceptions[74,90], such as the compatibility of organ donation with their religion[91].
Ethnicity & gender In multi-ethnic societies, the perception of discrimination in
healthcare services exists[92]. In general, patients and relatives usually
have greater satisfaction when encountering with race-concordant physicians[93]. The
easier reflection of emotional context in the qualities of race-concordant
voice tone, easier conveying of friendliness and social talks, and the sense of
racial or social group affiliation allow deeper engagement in communication,
cultivation of patient-physician relationship and development of mutual trust
in race-concordant encounters[94].
It is uneasy for the
doctors to achieve complete gender-neutrality[95]. It is
not surprising that the gender of attending physicians also affects the
patients’ and families’ hospital experience and satisfaction towards clinical
care[96-97]. This is due to patients’ gender-specific expectations of non-verbal
behaviours and patterns of physicians[96]. For both
genders, patients tend to expect their non-verbal behaviours to be mostly or
partly congruent with their gender role[96].
Therefore, awareness of the effects of race-concordant experiences and
these gender-specific expectations may have positive impacts when HCPs or organ
procurement staffs approach the patients and relatives for corneal donation
request.
Importation of
corneal grafts In the past, many countries have been receiving corneal importation from
the United States (up to US$ 4000 per cornea[98]) and Sri Lanka (US$
800-1500 per cornea[98]). The United States is the world’s biggest corneal provider. However,
the cost incurred has been a consistent issue. While EBAA members can fulfil
the demand of corneas in the United States with own donations, they can export
15 702 corneas to other eye banks (EBAA-accredited and -non-accredited) in 2014[99]. Sri Lanka
International Eye Bank, and now the Eye Donation Society, had donated over 118
000 corneas to the recipients all around the world since its establishment in
1961: over 53 830 corneas exported for transplantations in 57 countries, 30 000
corneas for research and development work and the rest for Sri Lankan
recipients[100]. First case of corneal exportation from Sri Lanka started was conducted
with the hand-carry of graft in an ice-packed tea thermos aboard a flight to
Singapore in 1964[77]. Since then, 117 towns in 57 countries had benefited from the gift of
sight from Sri Lankans.
The basic expenses of
corneal importation are usually the operational cost, tissue recovery,
preparation, cutting, preservation and packaging cost, and courier cost.
However, the quality control of grafts in Sri Lanka was discovered to be an
essential issue, such as infected donor cornea[101].
In February 2011,
Singapore Eye Bank had teamed up with the health authorities of Sri Lanka and
set up an official alliance as the National Eye Bank of Sri Lanka (NEBSL),
sited in the Colombo National Eye Hospital, to procure cornea donations from
Sri Lanka’s local donors, and process and distribute the high quality corneas
for transplantation cost-effectively. This is achieved through modelling NEBSL
after Singapore Eye Bank (SEB)[102], adoption of modified EBAA guidelines and the provision of technical
and expertise support and training by SEB[103]. NEBSL has a huge,
favourable potential of procuring large number of high-quality corneas a year
(1072 grafts for transplants in 2014) and re-emerge as the limelight eye bank
in Asia[104].
Artificial corneas, biosynthetic corneas & xenografts In view of the corneal graft scarcity, Keratoprostheses (KPros) may be
an effective alternative to address the burden of end-stage ocular surface
disease, failure(s) of previous corneal transplantation and high-risk corneal
grafts[105-109]. Boston KPro and Osteo-Odonto-Keratoprostheses (OOKP) are the commonest
adopted keratoprostheses in clinical practice. In order to reduce the financial
barrier, alternative lower-cost keratoprostheses are now being manufactured[45].
However, the usage of
Boston KPro is limited by an array of blinding complications especially in the
long run, such as formation of retroprosthetic membrane[106]), glaucoma, lifelong need for daily antibiotics and soft contact lens usage, endophthalmitis[106], corneal melt and
implant extrusion[105-106,108-109].
On the other hand,
although OOKP has higher retention rate[110] and better
resilience to dryness. However the requirement of multidisciplinary, dedicated
surgical units to support such complex multi-staged surgery and distortion to
recipient’s external appearance has limited its widespread clinical application[105,110-112].
Xenograft may be a
potential alternative especially for anterior lamellar keratoplasty. However,
the immunological barrier, especially the immune response against the corneal
endothelial cells is the greatest hurdle[113]. Genetic
engineering of pigs, clean and controlled environments for breeding and housing
pigs, and decellularization techniques seem to be optimistic solutions for the
immune response and the risk of transfer of potentially infectious
microorganisms from pigs to humans[114-115].
Cultivated corneal
endothelial cells may ease the requirement of endothelial keratoplasty in the
future[116-118]. There are two approaches: 1) "corneal
endothelial cell sheet transplantation" with cells grown on a type-I
collagen carrier[119]; 2) "endothelial cell injection therapy" (into the anterior
chamber) together with the application of Rho-kinase (ROCK) inhibitor[116,120]. ROCK inhibitor had been demonstrated to accelerate corneal wound
healing and successfully regenerate a corneal endothelial monolayer with a high
endothelial cell density in animal models via promotion cell adhesion
and proliferation and inhibition the apoptosis of corneal endothelial cells[116]. However,
no data on long-term safety is available to date.
With the increasing
popularity and sharing of expertise in the use of keratoprostheses, the
indications for KPro has expanded considerably, however the burden of drastic
ocular complications and incomplete understanding of their treatment remain a
hurdle for KPro to replace human corneas. On the other hand, xenografts and
cell based therapy with ROCK inhibitor application seem to be holding greater
potential for selected cases of corneal replacement (anterior lamella and
endothelium respectively) in the future[113-116,119-120].
To date, corneal
blindness still remains a major global health issue. The underlying cause of
corneal graft scarcity is multifactorial and jointly contributed by the
patients, families, HCPs, organ procurement organisations, eye bank systems and
government factors. At this stage, the most realistic and effective way of
improving graft donation could be the development of efficient and proficient
eye bank services which function to maintain the provision of high quality
corneal grafts and bridge the gap between demand and supply. Proactive
multifaceted and multi-level approaches are warranted to tackle this predicament,
with a view of improving donation rate while looking for practical
alternatives.
Conflicts
of Interest: Wong KH, None; Kam KW, None; Chen LJ, None; Young AL, None.
1 Abuksis G, Orenstein S,
Hershko A, Michowiz R, Livne M, Loia N, Kremer I, Winbereger D. Cornea
recipients: are their opinions and attitudes toward organ donation different
from those of the general population? Transplant
Proc 2004;36(5):1249-1252. [CrossRef] [PubMed]
2 McColgan K. Corneal
transplant surgery. J Perioper Pract
2009;19(2): 51-54. [PubMed]
4 Morchen M, Langdon T, Ormsby
GM, Meng N, Seiha D, Piseth K, Keeffe JE. Prevalence of blindness and cataract
surgical outcomes in Takeo Province, Cambodia. Asia Pac J Ophthalmol (Phila) 2015;4(1):25-31. [CrossRef] [PubMed]
5 Yan X, Congdon N, He M.
Prevention of cataract blindness in rural China. Asia Pac J Ophthalmol (Phila) 2012;1(2):69-71. [CrossRef] [PubMed]
7 Pascolini D, Mariotti SP.
Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96(5):614-618. [CrossRef] [PubMed]
8 Whitcher JP, Srinivasan M,
Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79(3):214-221. [PMC free article] [PubMed]
9 Dandona R, Dandona L.
Corneal blindness in a southern Indian population: need for health promotion
strategies. Br J Ophthalmol 2003;
87(2):133-141. [CrossRef] [PMC free article] [PubMed]
11 Gain P, Jullienne R, He Z,
Aldossary M, Acquart S, Cognasse F, Thuret G. Global survey of corneal
transplantation and eye banking. JAMA
Ophthalmol 2016;134(2):167-173. [CrossRef] [PubMed]
12 Gain P, Jullienne R, He Z,
Aldossary M, Acquart S, Cognasse F, Thuret G. Global survey of corneal
transplantation and eye banking (supplementary online content). JAMA Ophthalmol 2016;134(2):167-173. [CrossRef] [PubMed]
13 Lawlor M, Kerridge I.
Anything but the eyes: culture, identity, and the selective refusal of corneal
donation. Transplantation
2011;92(11):1188-1190. [CrossRef] [PubMed]
14 Lee WB, Jacobs DS, Musch
DC, Kaufman SC, Reinhart WJ, Shtein RM. Descemet's stripping endothelial
keratoplasty: safety and outcomes: a report by the American Academy of
Ophthalmology. Ophthalmology
2009;116(9):1818-1830. [CrossRef] [PubMed]
15 Terry MA. The evolution of
lamellar grafting techniques over twenty-five years. Cornea 2000;19(5):611-616. [CrossRef]
16 Young AL, Kam KW, Jhanji V,
Cheng LL, Rao SK. A new era in corneal transplantation: paradigm shift and
evolution of techniques. Hong Kong Med J
2012;18(6):509-516. [PubMed]
17 Tan DT, Mehta JS. Future
directions in lamellar corneal transplantation. Cornea 2007;26(9 Suppl 1):S21-S28. [CrossRef] [PubMed]
18 Tan DT, Dart JK, Holland
EJ, Kinoshita S. Corneal transplantation. Lancet
2012;379(9827):1749-1761. [CrossRef]
19 Fernandez MM, Afshari NA.
Endothelial keratoplasty: from DLEK to DMEK. Middle East Afr J Ophthalmol 2010;17(1):5-8. [PMC free article] [PubMed]
20 Young AL, Rao SK, Lam DS.
Endothelial keratoplasty: where are we? Clin
Exp Ophthalmol 2008;36(8):707-708. [CrossRef] [PubMed]
21 Vajpayee RB, Sharma N,
Jhanji V, Titiyal JS, Tandon R. One donor cornea for 3 recipients: a new
concept for corneal transplantation surgery. Arch Ophthalmol 2007;125(4):552-554. [CrossRef] [PubMed]
22 Alio JL, Shah S, Barraquer
C, Bilgihan K, Anwar M, Melles GR. New techniques in lamellar keratoplasty. Curr Opin Ophthalmol 2002;13(4):
224-229. [CrossRef]
23 Fontana L, Parente G,
Tassinari G. Simple test to confirm cleavage with air between Descemet's
membrane and stroma during big-bubble deep anterior lamellar keratoplasty. J Cataract Refract Surg
2007;33(4):570-572. [CrossRef] [PubMed]
24 Boynton GE, Woodward MA.
Eye-bank preparation of endothelial tissue. Curr
Opin Ophthalmol 2014;25(4):319-324. [CrossRef] [PMC free article] [PubMed]
25 Sinha R, Jhanji V, Verma K,
Sharma N, Biswas NR, Vajpayee RB. Efficacy of topical cyclosporine A 2% in
prevention of graft rejection in high-risk keratoplasty: a randomized
controlled trial. Graefes Arch Clin Exp
Ophthalmol 2010;248(8):1167-1172. [CrossRef] [PubMed]
26 Yamazoe K, Yamazoe K,
Yamaguchi T, Omoto M, Shimazaki J. Efficacy and safety of systemic tacrolimus
in high-risk penetrating keratoplasty after graft failure with systemic
cyclosporine. Cornea
2014;33(11):1157-1163. [CrossRef] [PubMed]
27 Chiba K. FTY720, a new
class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid
tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol Ther 2005;108(3):308-319. [CrossRef] [PubMed]
28 Gao M, Liu Y, Xiao Y, Han
G, Jia L, Wang L, Lei T, Huang Y. Prolonging survival of corneal
transplantation by selective sphingosine-1-phosphate receptor 1 agonist. PLoS One 2014;9(9):e105693. [CrossRef] [PMC free article] [PubMed]
29 Jia L, Liu Y, Wang L, Zhu
J, Huang Y. Effects of topical sphingosine-1-phosphate 1 receptor agonist on
corneal allograft in mice. Cornea
2014;33(4):398-404. [CrossRef] [PubMed]
30 Tan DT, Anshu A. Anterior
lamellar keratoplasty: 'Back to the Future'- a review. Clin Exp Ophthalmol 2010;38(2):118-127. [PubMed]
31 Reinhart WJ, Musch DC,
Jacobs DS, Lee WB, Kaufman SC, Shtein RM. Deep anterior lamellar keratoplasty
as an alternative to penetrating keratoplasty a report by the american academy
of ophthalmology. Ophthalmology
2011;118(1):209-218. [CrossRef] [PubMed]
34 Wakefield CE, Watts KJ,
Homewood J, Meiser B, Siminoff LA. Attitudes toward organ donation and donor
behavior: a review of the international literature. Prog Transplant 2010;20(4):380-391. [CrossRef]
36 Medicare and Medicaid
programs; hospital conditions of participation; identification of potential
organ, tissue, and eye donors and transplant hospitals' provision of
transplant-related data--HCFA. Final rule. Fed
Regist 1998;63(119):33856-33875. [PubMed]
37 Siminoff LA, Gordon N,
Hewlett J, Arnold RM. Factors influencing families' consent for donation of
solid organs for transplantation. JAMA
(2001);286(1):71-77. [CrossRef] [PubMed]
39 Chan TM. Donor shortage in
organ transplantation: perspective from Hong Kong. Transplant Proc 2002;34(7):2558-2559. [CrossRef]
40 Ho S, Cheng B. Overview of
transplant co-ordination service in Hong Kong. Hong Kong J Nephrol 1999;1(1):68-70. [CrossRef]
41 Cheng B, Ho CP, Ho S, Wong
A. An overview on attitudes towards organ donation in Hong Kong. Hong Kong J Nephrol 2005;7(2):77-81. [CrossRef]
42 Wu AM. Discussion of
posthumous organ donation in Chinese families. Psychol Health Med 2008;13(1):48-54. [CrossRef] [PubMed]
44 Oliva MS, Schottman T,
Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol (2012);60(5):423-427. [CrossRef] [PMC free article] [PubMed]
45 Pineda R. Corneal
transplantation in the developing world: lessons learned and meeting the
challenge. Cornea 2015;34(Suppl
10):S35-S40. [CrossRef] [PubMed]
46 Rao GN, Gopinathan U. Eye
banking: an introduction. Community Eye
Health 2009;22(71):46-47. [PMC free article] [PubMed]
49 Sander SL, Miller BK.
Public knowledge and attitudes regarding organ and tissue donation: an analysis
of the northwest Ohio community. Patient
Educ Couns 2005;58(2):154-163. [CrossRef] [PubMed]
50 Alghanim SA. Knowledge and
attitudes toward organ donation: a community-based study comparing rural and
urban populations. Saudi J Kidney Dis
Transpl 2010;21(1):23-30. [PubMed]
51 Schaeffner ES, Windisch W,
Freidel K, Breitenfeldt K, Winkelmayer WC. Knowledge and attitude regarding
organ donation among medical students and physicians. Transplantation 2004;77(11):1714-1718. [CrossRef]
52 Bardell T, Childs AL,
Hunter DJ. Organ donation: a pilot study of knowledge among medical and other
university students. Ann R Coll
Physicians Surg Can 2002;35(2):77-80. [PubMed]
53 Breitkopf CR. Attitudes,
beliefs and behaviors surrounding organ donation among Hispanic women. Curr Opin Organ Transplant 2009;
14(2):191-195. [CrossRef]
54 Etheredge HR, Turner RE,
Kahn D. Public attitudes to organ donation among a sample of urban-dwelling
South African adults: a 2012 study. Clin
Transplant 2013;27(5):684-692. [CrossRef]
55 Mohamed E, Guella A. Public
awareness survey about organ donation and transplantation. Transplant Proc 2013;45(10):3469-3471. [CrossRef] [PubMed]
56 Molzahn AE. Knowledge and
attitudes of critical care nurses regarding organ donation. Can J Cardiovasc Nurs 1997;8(2):13-18. [PubMed]
57 Molzahn AE. Knowledge and
attitudes of physicians regarding organ donation. Ann R Coll Physicians Surg Can 1997;30(1):29-32. [PubMed]
58 Brkljacic T, Feric I,
Rihtar S. Development and testing of promotion materials on tissue and organ
donation. Croat Med J
2003;44(2):225-233. [PubMed]
59 Cornwall J, Schafer C, Lal
N, D'Costa R, Nada-Raja S. New Zealand University students' knowledge and
attitudes to organ and tissue donation. N
Z Med J 2015;128(1418):70-79. [PubMed]
60 Li PK, Lin CK, Lam PK,
Szeto CC, Lau JT, Cheung L, Wong M, Chan AY, Ko WM. Attitudes about organ and
tissue donation among the general public and blood donors in Hong Kong. Prog Transplant 2001;11(2):98-103. [CrossRef]
61 Goz F, Goz M, Erkan M. Knowledge and attitudes of medical, nursing,
dentistry and health technician students towards organ donation: a pilot study.
J Clin Nurs 2006;15(11):1371-1375. [CrossRef] [PubMed]
62 Morgan M, Kenten C, Deedat S. Attitudes to deceased organ donation
and registration as a donor among minority ethnic groups in North America and
the U.K.: a synthesis of quantitative and qualitative research. Ethn Health 2013;18(4):367-390. [CrossRef] [PubMed]
63 Guden E, Cetinkaya F, Nacar M. Attitudes and behaviors regarding
organ donation: a study on officials of religion in Turkey. J Relig Health 2013;52(2):439-449. [CrossRef] [PubMed]
64 Keten HS, Keten D, Ucer H, Cerit M, Isik O, Miniksar OH, Ersoy O.
Knowledge, attitudes, and behaviors of mosque imams regarding organ donation. Ann Transplant 2014;19:598-603. [CrossRef] [PubMed]
65 DuBois JM, Anderson EE. Attitudes toward death criteria and organ
donation among healthcare personnel and the general public. Prog Transplant 2006;16(1):65-73. [CrossRef] [PubMed]
66 Bapat U, Kedlaya PG. Organ donation, awareness, attitudes and beliefs
among post graduate medical students. Saudi
J Kidney Dis Transpl 2010;21(1):174-180. [PubMed]
67 Nacar M, Cetinkaya F, Baykan Z, Poyrazoğlu S. Attitudes and
behaviours of students from the faculty of theology regarding organ donation: a
study from Turkey. Transplant Proc
2009;41(10):4057-4061. [CrossRef] [PubMed]
68 Golchet G, Carr J, Harris MG. Why don't we have enough cornea donors?
A literature review and survey. Optometry
2000;71(5):318-328. [PubMed]
69 Ozer A, Ekerbicer HC, Celik M, Nacar M. Knowledge, attitudes, and
behaviors of officials of religion about organ donation in Kahramanmaras, an
eastern Mediterranean city of Turkey. Transplant
Proc 2010;42(9):3363-3367. [CrossRef] [PubMed]
70 Padela AI, Rasheed S, Warren GJ, Choi H, Mathur AK. Factors
associated with positive attitudes toward organ donation in Arab Americans. Clin Transplant 2011;25(5):800-808. [CrossRef] [PubMed]
71 Anker AE, Feeley TH. Why families decline donation: the perspective
of organ procurement coordinators. Prog
Transplant 2010;20(3):239-246. [CrossRef] [PubMed]
72 Rodrigue JR, Cornell DL, Howard RJ. Relationship of exposure to organ
donation information to attitudes, beliefs, and donation decisions of next of
kin. Prog Transplant
2009;19(2):173-179. [CrossRef]
73 Brzezinski M, Klikowicz P. Facebook as a medium for promoting
statement of intent for organ donation: 5-years of experience. Ann Transplant 2015;20:141-146. [CrossRef] [PubMed]
74 Rokade SA, Gaikawad AP. Body donation in India: social awareness,
willingness, and associated factors. Anat
Sci Educ 2012;5(2):83-89. [CrossRef] [PubMed]
75 Li AH, Rosenblum AM, Nevis IF, Garg AX. Adolescent classroom
education on knowledge and attitudes about deceased organ donation: a
systematic review. Pediatr Transplant
2013;17(2):119-128. [CrossRef] [PubMed]
76 Lawlor M, Kerridge I. Understanding selective refusal of eye
donation. Identity, beauty, and interpersonal relationships. J Bioeth Inq 2014;11(1):57-64. [CrossRef] [PubMed]
78 Franz HG, DeJong W, Wolfe SM, Nathan H, Payne D, Reitsma W, Beasley
C. Explaining brain death: a critical feature of the donation process. J Transpl Coord 1997;7(1):14-21. [CrossRef]
79 Siminoff LA, Mercer MB, Arnold R. Families' understanding of brain
death. Prog Transplant
2003;13(3):218-224. [CrossRef]
80 Aghayan HR, Arjmand B, Emami-Razavi SH, Jafarian A, Shabanzadeh AR,
Jalali F, Goodarzi P, Jebelifar S. Organ donation workshop - a survey on
nurses' knowledge and attitudes toward organ and tissue donation in Iran. Int J Artif Organs 2009;32(10):739-744.
[PubMed]
81 Smudla A, Mihály S, Okrös I, Hegedűs K, Fazakas J. The attitude and
knowledge of intensive care physicians and nurses regarding organ donation in
Hungary--it needs to be changed. Ann
Transplant 2012;17(3):93-102. [CrossRef]
82 Bener A, El-Shoubaki H, Al-Maslamani Y. Do we need to maximize the
knowledge and attitude level of physicians and nurses toward organ donation and
transplant? Exp Clin Transplant
2008;6(4):249-253. [PubMed]
83 Coleman-Musser L. The physician's perspective: a survey of attitudes
toward organ donor management. J Transpl
Coord 1997;7(2):55-58. [CrossRef]
84 Siminoff LA, Arnold R, Miller DS. Differences in the procurement of
organs and tissues by health care professionals. Clin Transplant 1994;8(5):460-465. [PubMed]
85 Bardell T, Hunter DJ, Kent WD, Jain MK. Do medical students have the
knowledge needed to maximize organ donation rates? Can J Surg 2003;46(6):453-457. [PMC free article] [PubMed]
86 Rykhoff ME, Coupland C, Dionne J, Fudge B, Gayle C, Ortner TL,
Quilang K, Savu G, Sawany F, Wrobleska M. A clinical group's attempt to raise
awareness of organ and tissue donation. Prog
Transplant 2010;20(1):33-39. [CrossRef] [PubMed]
87 Williams MA, Lipsett PA, Rushton CH, Grochowski EC, Berkowitz ID,
Mann SL, Shatzer JH, Short MP, Genel M; Council on Scientific Affairs, American
Medical Association. The physician's role in discussing organ donation with
families. Crit Care Med
2003;31(5):1568-1573. [CrossRef] [PubMed]
88 Hafzalah M, Azzam R, Testa G, Hoehn KS. Improving the potential for
organ donation in an inner city Muslim American community: the impact of a
religious educational intervention. Clin
Transplant 2014;28(2):192-197. [CrossRef] [PubMed]
89 Bae HS, Brown WJ, Kang S. Social influence of a religious hero: the
late Cardinal Stephen Kim Sou-hwan's effect on cornea donation and
volunteerism. J Health Commun
2011;16(1):62-78. [CrossRef] [PubMed]
90 Salim A, Bery C, Ley EJ, Schulman D, Navarro S, Zheng L, Chan LS. A
focused educational program after religious services to improve organ donation
in Hispanic Americans. Clin Transplant
2012;26(6):E634-E640. [CrossRef] [PMC free article] [PubMed]
91 Muliira RS, Muliira JK. A review of potential Muslim organ donors'
perspectives on solid organ donation: lessons for nurses in clinical practice. Nurs Forum 2014;49(1):59-70. [CrossRef] [PubMed]
92 Johansson P, Jacobsen C, Buchwald D. Perceived discrimination in
health care among American Indians/Alaska natives. Ethn Dis 2006;16(4):766-771. [PubMed]
93 van Zanten M, Boulet JR, McKinley DW. The influence of ethnicity on
patient satisfaction in a standardized patient assessment. Acad Med 2004;79(10 Suppl):S15-S17. [CrossRef] [PubMed]
94 Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR.
Patient-centered communication, ratings of care, and concordance of patient and
physician race. Ann Intern Med
2003;139(11):907-915. [CrossRef]
95 Lagro-Janssen AL. Medicine is not gender-neutral: influence of
physician sex on medical care. Ned
Tijdschr Geneeskd 2008;152(20): 1141-1145. [PubMed]
96 Mast MS, Hall JA, Köckner C, Choi E. Physician gender affects how
physician nonverbal behavior is related to patient satisfaction. Med Care 2008;46(12):1212-1218. [CrossRef] [PubMed]
97 Schmid Mast M, Hall JA, Roter DL. Disentangling physician sex and
physician communication style: their effects on patient satisfaction in a virtual
medical visit. Patient Educ Couns
2007;68(1):16-22. [CrossRef] [PubMed]
101 Lam DS, Kwok AK, Chew S. Post-keratoplasty endophthalmitis caused by
Proteus mirabilis. Eye (Lond)
1998;12(Pt 1)139-140. [CrossRef] [PubMed]
105 Avadhanam VS, Liu CS. A brief review of Boston type-1 and
osteo-odonto keratoprostheses. Br J
Ophthalmol 2015;99(7):878-887. [CrossRef] [PubMed]
106 Al Arfaj K. Boston keratoprosthesis - Clinical outcomes with wider
geographic use and expanding indications -A systematic review. Saudi J Ophthalmol 2015;29(3):212-221. [CrossRef] [PMC free article] [PubMed]
107 Hager JL, Phillips DL, Goins KM, Kitzmann AS, Greiner MA, Cohen AW,
Welder JD, Wagoner MD. Boston type 1 keratoprosthesis for failed keratoplasty. Int Ophthalmol 2016;36(1):73-78. [CrossRef] [PubMed]
108 Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and
complications with the Boston type 1 keratoprosthesis at the University of
California, Davis. Ophthalmology
2011;118(8):1543-1550. [CrossRef] [PubMed]
109 Iyer G, Srinivasan B, Gupta N, Padmanabhan P. Outcome of Boston
keratoprosthesis in a developing country-importance of patient selection,
education, and perioperative care: the Indian experience. Asia Pac J Ophthalmol (Phila) 2012;1(4):202-207. [CrossRef] [PubMed]
110 Tan A, Tan DT, Tan XW, Mehta JS. Osteo-odonto keratoprosthesis:
systematic review of surgical outcomes and complication rates. Ocul Surf 2012;10(1):15-25. [CrossRef] [PubMed]
111 Hughes EH, Mokete B, Ainsworth G, Casswell AG, Eckstein MB,
Zambarakji HJ, Gregor Z, Rosen PH, Herold J, Okera S, Liu CS. Vitreoretinal
complications of osteoodontokeratoprosthesis surgery. Retina 2008;28(8):1138-1145. [CrossRef] [PubMed]
113 Lamm V, Hara H, Mammen A, Dhaliwal D, Cooper DK. Corneal blindness
and xenotransplantation. Xenotransplantation
2014;21(2):99-114. [CrossRef] [PMC free article] [PubMed]
114 Cooper DK, Ekser B, Ramsoondar J, Phelps C, Ayares D. The role of
genetically engineered pigs in xenotransplantation research. J Pathol 2016;238(2):288-299. [CrossRef] [PMC free article] [PubMed]
115 Hara H, Cooper DK. Xenotransplantation-the future of corneal
transplantation? Cornea
2011;30(4):371-378. [CrossRef] [PMC free article] [PubMed]
116 Koizumi N, Okumura N, Kinoshita S. Development of new therapeutic
modalities for corneal endothelial disease focused on the proliferation of
corneal endothelial cells using animal models. Exp Eye Res 2012;95(1):60-67. [CrossRef] [PubMed]
117 Liu Y, Wang J, Luo Y, Chen S, Lewallen M, Xie T. Stem cells and
ocular tissue regeneration. Asia Pac J
Ophthalmol (Phila) 2013;2(2):111-118. [CrossRef] [PubMed]
118 Nakamura T, Inatomi T, Sotozono C, Koizumi N, Kinoshita S. Recent
advances and future challenges in ocular surface reconstruction: on the road to
translational medicine. Asia Pac J
Ophthalmol (Phila) 2012;1(1):28-34. [CrossRef] [PubMed]
119 Koizumi N, Sakamoto Y, Okumura N, Tsuchiya H, Torii R, Cooper LJ,
Ban Y, Tanioka H, Kinoshita S. Cultivated corneal endothelial transplantation
in a primate: possible future clinical application in corneal endothelial
regenerative medicine. Cornea
2008;27(Suppl 1)S48-S55. [CrossRef] [PubMed]
120 Okumura N, Kinoshita S, Koizumi N. Cell-based approach for treatment
of corneal endothelial dysfunction. Cornea
2014;33(Suppl 11):S37-S41. [CrossRef] [PubMed]